封面
市場調查報告書
商品編碼
1747600

分子細胞遺傳學市場(按產品類型、技術、應用和地區分類)

Molecular Cytogenetics Market, By Product Type, By Technology, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

分子細胞遺傳學市場規模預計在 2025 年為 65.272 億美元,預計到 2032 年將達到 302.63 億美元,2025 年至 2032 年的複合年成長率為 24.5%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 65.272億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 24.50% 2032年價值預測 302.63億美元

分子細胞遺傳學是分子生物學和細胞遺傳學的結合。分子細胞遺傳學涵蓋染色體生物學的各個方面,在疾病診斷和染色體異常方面有著廣泛的應用。分子細胞遺傳學可以區分正常細胞和癌細胞。在分子細胞遺傳學中,會使用螢光原位雜合技術 (FISH) 等技術,其中 DNA 探針以不同顏色的螢光標籤標記,以可視化整個螢光或基因組中最特異性的區域。分子細胞雜合反應有助於研究染色體及其細胞核的結構和功能組織、基因組突變、表現和演化,以及醫學和癌症相關遺傳學中的染色體異常。癌症的高發生率以及分子生物學在檢測與癌症市場發展相關的遺傳易感性方面的應用日益廣泛,預計將推動全球分子細胞遺傳學市場的成長。

市場動態

為了透過在產品系列中添加先進的 PSS 硬體、軟體、色譜柱和標準來加強和確保提供廣泛的產品(例如 LC 儀器、GPC/SEC 分析),主要市場參與企業正專注於採用收購等成長策略,這有助於全球分子細胞遺傳學市場的成長。例如,2022 年 8 月,儀器、軟體和服務供應商安捷倫科技公司宣布已收購聚合物表徵領域的解決方案供應商Polymer Standards Service GmbH (PSS)。 PSS 專門提供用於定義和創建分子結構的硬體和軟體解決方案。該公司提供凝膠滲透層析法(GPC) 和尺寸排阻層析法(SEC) 的完整解決方案,用於測量聚合物的分子量和尺寸分佈。

本研究的主要特點

  • 本報告對全球分子細胞遺傳學市場進行了詳細分析,並以 2024 年為基準年,提供了 2025 年至 2032 年預測期的市場規模和年複合成長率(CAGR)。
  • 它還強調了各個領域的潛在商機,並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球分子細胞遺傳學市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球分子細胞遺傳學市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球分子細胞遺傳學市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 限制因素
  • 市場機會
  • 影響分析
  • 最新產品發布
  • 流行病學
  • 合併、收購和合作
  • 監管情景
  • 主要進展
  • PEST分析

4. 2020 年至 2032 年全球分子細胞遺傳學市場(依產品類型)

  • 裝置
  • 耗材
  • 軟體和服務

5. 全球分子細胞遺傳學市場(依技術分類),2020 年至 2032 年

  • FISH
  • aCGH

6. 全球分子細胞遺傳學市場(按應用分類),2020 年至 2032 年

  • 遺傳性疾病
  • 癌症
  • 個人化醫療
  • 其他

7. 全球分子細胞遺傳學市場(按地區分類),2020 年至 2032 年

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第8章 競爭態勢

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Applied Spectral Imaging, Inc.
  • BI Biological Industries
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific Inc.
  • CytoTest Inc.
  • Cytognomix, Inc.
  • Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Bionano Genomics, Inc.
  • Precipio, Inc.
  • Leica Biosystems

第9章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI2491

Molecular Cytogenetics Market is estimated to be valued at USD 6,527.2 Mn in 2025 and is expected to reach USD 30,263 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 24.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6,527.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 24.50% 2032 Value Projection: USD 30,263 Mn

Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. Molecular cytogenetics includes all the aspects of chromosome biology with a wide range of applications in disease diagnosis and chromosomal abnormalities. It enables to differentiate normal and cancer causing cells. In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome. Molecular cytogenetics helps to study the structural and functional organization of chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities in medicinal and cancer-related genetics. The high prevalence of cancer and increasing application of molecular biology in the detection of inherited susceptibilities associated with cancer development is expected to boost the global molecular cytogenetics market growth.

Market Dynamics

To add advanced PSS hardware, software, columns, and reference materials to the product portfolio which will enhance the offerings and ensure delivery of the broad spectrum of LC equipment, GPC/SEC analytics, the key market players are focusing on adoption of growth strategies such as acquisition which is attributed to the growth of global molecular cytogenetics market. For instance, in August 2022, Agilent Technologies Inc., provider of instruments, software, services, etc., announced it has acquired Polymer Standards Service GmbH (PSS) a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.

Key features of the study

  • This report provides an in-depth analysis of the global molecular cytogenetics market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global molecular cytogenetics market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global molecular cytogenetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular cytogenetics market

Market Segmentation

  • Global Molecular Cytogenetics Market, By Product Type
    • Instruments
    • Consumables
    • Software and Services
  • Global Molecular Cytogenetics Market, By Technology
    • FISH
    • aCGH
  • Global Molecular Cytogenetics Market, By Application
    • Genetic Disorders
    • Cancer
    • Personalized Medicine
    • Others
  • Global Molecular Cytogenetics Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Abbott Laboratories
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Applied Spectral Imaging, Inc.
    • BI Biological Industries
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific Inc.
    • CytoTest Inc.
    • Cytognomix, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Bionano Genomics, Inc.
    • Precipio, Inc.
    • Leica Biosystems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Molecular Cytogenetics Market, By Product Type, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

5. Global Molecular Cytogenetics Market, By Technology, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • FISH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • aCGH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Molecular Cytogenetics Market, By Application, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Genetic Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Molecular Cytogenetics Market, By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Affymetrix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Applied Spectral Imaging, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BI Biological Industries
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CytoTest Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cytognomix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bionano Genomics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Precipio, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Leica Biosystems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us